![Pernilla Abrahamsson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Pernilla Abrahamsson
Geschäftsführer bei
LIPUM AB
Profil
Pernilla Abrahamsson is the founder of MD Biomedical AB. She is currently the Chief Operating Officer at Lipum AB. Previously, she worked as Manager-Product Development at Senzime AB from 2018 to 2019.
Dr. Abrahamsson obtained a doctorate degree from Umea Universitet.
Aktive Positionen von Pernilla Abrahamsson
| Unternehmen | Position | Beginn |
|---|---|---|
| LIPUM AB | Geschäftsführer | 01.01.2019 |
Ehemalige bekannte Positionen von Pernilla Abrahamsson
| Unternehmen | Position | Ende |
|---|---|---|
| SENZIME AB | Corporate Officer/Principal | 01.04.2019 |
MD Biomedical AB
 MD Biomedical AB Medical/Nursing ServicesHealth Services Provides micro dialysis products and services | Gründer | - |
Ausbildung von Pernilla Abrahamsson
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
17
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Senzime AB
 Senzime AB Medical SpecialtiesHealth Technology Develops and markets an enzyme based biosensor technology | Health Technology |
Umea Universitet
 Umea Universitet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MD Biomedical AB
MD Biomedical AB Medical/Nursing ServicesHealth Services Provides micro dialysis products and services | Health Services |
Lipum AB
 Lipum AB BiotechnologyHealth Technology Develops biological anti-inflammatory drugs | Health Technology |
